Skip to main content

Radiotherapy & Oncology

  • ISSN: 0167-8140

Editor-In-Chief: Baumann

Next planned ship date: April 12, 2024

  • 5 Year impact factor: 5.8
  • Impact factor: 5.7

Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation OncologyESTRO members can access Radiotherapy and Oncology on… Read more

Subscription options

Next planned ship date:
April 12, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation Oncology
ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.

Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.



Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.



Editorial Office:
Professor Michael Baumann, Editor-in-Chief, Radiotherapy and Oncology Editorial Office, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany (email: [email protected]).